Disappearing Term Sheets and Down Rounds: Inside Venture Capital’s New Normal
Information, TheInformation, The
Businesses are increasingly faced with the challenge of keeping pace with accelerating innovation to sustain and grow their businesses and adapt to changes in their markets. We advise companies looking to make strategic investments in new technologies and commercial partnerships with innovative startups to enable them to adopt and accelerate innovation and best adapt to the changing marketplace.
Entire VC Ecosystem Experience. Our lawyers are experienced in structuring and building from inception, managing and monitoring, and ultimately monetizing, corporate venture capital (CVC) portfolios. We know what's market in corporate venture capital investments and commercial transactions. We have represented corporate venture funds, strategic acquirors, venture capital funds, advisors, underwriters, early-stage and emerging growth businesses, and entrepreneurs in all stages of the company life cycle, from formation through the exit.
IP Experience. Our leading 180-member IP group holds over 200 scientific and technical degrees (including 105 in computing or electrical engineering) and provides targeted due diligence and guidance on structuring and portfolio management.
International Impact. We have substantial experience handling cross-border CVC investments, including Silicon Valley, Texas, New York, Eastern and Western Europe, Middle East and Asia. We have significant experience in representing both U.S. investors focused on global investments as well as non-U.S. investors focused on U.S. investments.
Our presence in the Silicon Valley and tech centers across the U.S., our global coverage and firmwide focus on the technology industry, and our deal work experience provide us deep exposure to deal trends and terms across industries and markets.
Our Corporate Venture Capital team advises client on all aspects of corporate venture end-to-end, including:
Due Diligence. We deploy interdisciplinary teams that mix corporate, IP, tax, regulatory and other relevant experience to tackle due diligence review of the target company's business arrangements, assets and liabilities, IP portfolio, R&D process, and compliance efforts. Whenever IP assets are developed or shared, Baker Botts IP lawyers have the technical and business experience to support the transaction. Our diverse due diligence experience spans all areas of technology, engineering, energy and life sciences.
Investment. Baker Botts lawyers are well versed in structuring and executing all manner of CVC investments, whether early, mid or late stage, and understand the intricacies of anti-dilution mechanics, liquidation preferences, voting rights and registration rights. We know what is market for these investments and what CVC investment terms look like. We understand the necessary balance of protecting and maximizing our client's financial return with promoting and facilitating the target's development of its product or service offerings and commercialization of its business.
Commercial Benefit. We provide creative and comprehensive transaction design, and execution approaches, with both technology and commercial business objectives in mind. We bring to the table 30+ years of tech sector experience advising on strategic commercial alliances, joint development and joint venture arrangements, often involving complex commercial licensing, and supply, marketing and distribution arrangements for critical or innovative technology. Our solutions are business-focused - we recognize each party's desire to maximize value and minimize risk while still creating a commercial relationship that allows for growth as business needs change.
Our CVC team integrates seamlessly with the firm's nationally ranked M&A and capital markets practices, helping our clients with the full spectrum of legal needs on their CVC investments.
Information, The
Deal Description: On October 26, 2021, CitizenMe Limited (CitizenMe) announced it had secured $2m in funding led by the North East Venture Fund (NEVF) alongside funds from 1818 Capital and private investors.
Community Impact
Pitchbook
Gaule's Question Time
Energy Update
Which Major Trends will Most Affect the Startup Community in 2021?
Corporate Update
Corporate Update
Corporate Update
Baker Botts (UK) LLP, in association with the Digital Health & Care Alliance and Ascendant Corporate Finance, will host its fourth annual Health Technology pitch event on Wednesday 5 February 2020 at the London Baker Botts office.
Baker Botts in partnership with NovAzure Consulting, is delighted to invite you to our 3rd annual Cleantech and Renewables pitch event on Tuesday 15 October 2019 at our London office.
Join us on 2 May as we partner with Metis Partners, to bring you the first in a series of seminars on the Lifecycle of a High Growth Company. From Term Sheets to Exit:
Baker Botts is sponsoring the Venture Houston Conference on November 8-9 in Houston.